دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Cover Image
Kamlesh Khunti F. MedSci, Volker Schnecke PhD, Christiane Lundegaard Haase PhD, Nina M. Harder-Lauridsen PhD, Naveen Rathor MD, Kasper Sommer MSc, Camilla S. Morgen PhD,Â
doi : 10.1111/dom.15242
Volume 25, Issue 9
The role of adiponectin for immune cell function in metabolic diseases
Mingyue Gao MM, Dawei Cui PhD, Jue Xie PhD,Â
doi : 10.1111/dom.15151
A micro-randomized pilot study to examine the impact of just-in-time nudging on after-dinner snacking in adults with type 2 diabetes: A study protocol
Lijun Zhao MD, Niranjan Bidargaddi PhD, Andrew Vakulin PhD, Wenhao Li PhD, Natalie Luscombe-Marsh PhD, Fiona Benton, Robert Adams MD, Eva Kemps PhD, Andrew D. Vincent, Leonie K. Heilbronn PhD, Gary A. Wittert MD,Â
doi : 10.1111/dom.15159
First-in-human study of a pharmacological duodenal exclusion therapy shows reduced postprandial glucose and insulin and increased bile acid and gut hormone concentrations
Mark S. Fineman PhD, Christine L. N. Bryant PhD, Kevin Colbert MS, Thomas H. Jozefiak PhD, John S. Petersen PhD, Michael Horowitz PhD, Jiten Vora MD, Christopher K. Rayner PhD, Paul Wabnitz MD, Ashish Nimgaonkar MD,Â
doi : 10.1111/dom.15066
Association between glycaemia risk index (GRI) and diabetic retinopathy in type 2 diabetes: A cohort study
Yaxin Wang MD, Jingyi Lu PhD, Jiaying Ni BS, Ming Wang BS, Yun Shen MD, Wei Lu BSN, Wei Zhu BSN, Yuqian Bao MD, David Rodbard MD, Robert A. Vigersky MD, Weiping Jia PhD, Jian Zhou PhD,Â
doi : 10.1111/dom.15068
Impact of pre-existing type 2 diabetes with and without cardiovascular disease on patients with COVID-19
Chi Nguyen PhD, Christopher L. Crowe MPH, Effie Kuti PharmD, Nihal Narsipur PharmD, Bonnie Donato PhD, Rebecca S. Pepe MPH, Rachel Djaraher MPH, Leo Seman MD, Nancy Graeter MS, Thomas P. Power MD, Rinku Mehra MD, Vincent J. Willey PharmD,Â
doi : 10.1111/dom.15069
Baseline determinants of remission of type 2 diabetes in response to short-term insulin-based therapy: The pivotal role of beta-cell function
Ravi Retnakaran MD, Jiajie Pu MMath, Alexandra Emery RN, Caroline K. Kramer MD, Bernard Zinman MD,Â
doi : 10.1111/dom.15073
Incidence, characteristics, risk factors and outcomes of diabetic ketoacidosis in COVID-19 patients: Comparison with influenza and pre-pandemic data
Kevin Dell'Aquila DO, Jeylin Lee, Stephen H. Wang MD, Tharun T. Alamuri BS, Rebecca Jennings BS, Helen Tang, Sandhya Mahesh, Taylor Jan Leong BS, Roman Fleysher PhD, Erin M. Henninger MS, Sudhakar Veeraraghavan MS, Parsa Mirhaji MD, Wei Hou PhD, Kevan C. Herold MD, Tim Q. Duong PhD,Â
doi : 10.1111/dom.15120
Comparative efficacy and safety of Gla-300 versus IDegAsp in insulin-naïve people with type 2 diabetes mellitus uncontrolled on oral anti-diabetics
Robert Ritzel MD, Sujoy Ghosh MD, Rifat Emral MD, Rachid Malek MD, Longyi Zeng PhD, Maria Aileen Mabunay MD, Wolfgang Landgraf PhD, Patricia Guyot PhD, Paul Serafini BA, Divya Pushkarna BTech, Rayaz A. Malik PhD,Â
doi : 10.1111/dom.15121
Stabilization of kidney function and reduction in heart failure events with sodium-glucose co-transporter 2 inhibitors: A meta-analysis and meta-regression analysis
Yamato Keidai MD, Satoshi Yoshiji MD, Masashi Hasebe MD, Hiroto Minamino MD, Takaaki Murakami MD, Daisuke Tanaka MD, Yoshihito Fujita MD, Nobuya Inagaki MD,Â
doi : 10.1111/dom.15122
Sulfatide inhibits fibroblast growth, activation and oxidative stress induced by ectopic insulin
Allan Roeske-Nielsen PhD, Jan-Eric MÃ¥nsson PhD, Hasim Tekin MSc, Klaus Rieneck MD, Klaus Bendtzen MD, Karsten Buschard MD,Â
doi : 10.1111/dom.15123
Advancing therapy in people with suboptimally controlled basal insulin-treated type 2 diabetes: Subanalysis of the SoliMix trial in participants in Latin American countries
Gustavo Frechtel MD, Leobardo Sauque-Reyna MD, Ricardo Choza-Romero MD, Luis Anguiano MD, Lydie Melas-Melt MSc, MarÃa Elena Sañudo-Maury MD,Â
doi : 10.1111/dom.15125
Clinical outcomes associated with drugs for obesity and overweight: A systematic review and network meta-analysis of randomized controlled trials
Andrea Iannone PhD, Patrizia Natale PhD, Suetonia C. Palmer PhD, Antonio Nicolucci PhD, Maria Rendina PhD, Francesco Giorgino PhD, Luigi Laviola PhD, Alfredo Di Leo PhD, Giovanni F. M. Strippoli PhD,Â
doi : 10.1111/dom.15138
The significance of coefficient of variation as a measure of hypoglycaemia risk and glycaemic control in real world users of the automated insulin delivery MiniMed 780G system
Javier Castañeda MS, Arcelia Arrieta MS, Tim van den Heuvel PhD, Ohad Cohen MD,Â
doi : 10.1111/dom.15139
Relationship between body weight change and glycaemic control with tirzepatide treatment in people with type 2 diabetes: A post hoc assessment of the SURPASS clinical trial programme
Sue D. Pedersen MD, Francesco Giorgino MD, Guillermo Umpierrez MD, Vivian T. Thieu PhD, Angel RodrÃguez MD, Claudia Nicolay PhD, Laura Fernández Landó MD, Chrisanthi A. Karanikas MS, Jacek Kiljanski MD,Â
doi : 10.1111/dom.15140
Circulating levels of proglucagon-derived peptides are differentially regulated by the glucagon-like peptide-1 agonist liraglutide and the centrally acting naltrexone/bupropion and can predict future weight loss and metabolic improvements: A 6-month long interventional study
Konstantinos Stefanakis MD, Alexander Kokkinos MD, Georgia Argyrakopoulou MD, Sofia K. Konstantinidou MSc, Stamatia Simati MD, Matina Kouvari PhD, Ajay Kumar PhD, Bhanu Kalra PhD, Melina Kumar, Nikolaos Bontozoglou MD, Konstantina Kyriakopoulou MD, Christos S. Mantzoros MD,Â
doi : 10.1111/dom.15141
Associations of diabetes, prediabetes and diabetes duration with the risk of chronic obstructive pulmonary disease: A prospective UK Biobank study
Jian Su MM, Mengyao Li MB, Xinglin Wan MB, Hao Yu PhD, Yanan Wan MM, Dong Hang PhD, Yan Lu MM, Ran Tao PhD, Ming Wu PhD, Jinyi Zhou MM, Xikang Fan PhD,Â
doi : 10.1111/dom.15142
Acute pharmacodynamic responses to exenatide: Drug-induced increases in insulin secretion and glucose effectiveness
Simeon I. Taylor MD, May E. Montasser PhD, Ashley H. Yuen MD, Hubert Fan BS, Zhinoosossadat Shahidzadeh Yazdi MD, Hilary B. Whitlatch MD, Braxton D. Mitchell PhD, Alan R. Shuldiner MD, Ranganath Muniyappa MD, Elizabeth A. Streeten MD, Amber L. Beitelshees PharmD,Â
doi : 10.1111/dom.15143
Perceptions, behaviours and potential barriers to effective obesity care. Results from the ACTION-DK study
Tina Vilsbøll MD, Sigrid Bjerge Gribsholt MD, Nils Bruun Jørgensen MD, Pernille Andreassen PhD, Per Nielsen, Cecilie Yssing MSc, Mette Bøgelund MSc, Signe Stensen PhD, Kasper Nørremark MSc, Jens Meldgaard Bruun MD,Â
doi : 10.1111/dom.15144
Evaluation of the effects of ezetimibe on albuminuria and kidney fat in individuals with type 2 diabetes and chronic kidney disease
Niels Søndergaard Heinrich PhD, Rune Ploegstra Pedersen BSc Eng, Mark Bitsch Vestergaard PhD, Ulrich Lindberg PhD, Ulrik Bjørn Andersen MD, Bryan Haddock PhD, Tine Willum Hansen PhD, Alessia Fornoni PhD, Henrik Bo Wiberg Larsson DMSc, Peter Rossing DMSc,Â
doi : 10.1111/dom.15146
Glycaemic patterns of male professional athletes with type 1 diabetes during exercise, recovery and sleep: Retrospective, observational study over an entire competitive season
Eva van Weenen MSc, Nicolas Banholzer PhD, Simon Föll MSc, Thomas Zueger MD, Federico Y. Fontana PhD, Kristina Skroce MSc, Charlotte Hayes MMSc, Mathias Kraus PhD, Stefan Feuerriegel PhD, Vera Lehmann MD, Sam N. Scott PhD, Felix Wortmann PhD, Christoph Stettler MD,Â
doi : 10.1111/dom.15147
Tirzepatide 10 and 15 mg compared with semaglutide 2.4 mg for the treatment of obesity: An indirect treatment comparison
Carel W. le Roux MD, Emily R. Hankosky PhD, Duzhe Wang PhD, Raleigh Malik PhD, Maria Yu MS, Ana Hickey PhD, Hong Kan PhD, Mathijs C. Bunck MD, Adam Stefanski MD, Luis-Emilio Garcia-Perez MD, Sean Wharton MD,Â
doi : 10.1111/dom.15148
Orforglipron (LY3502970), a novel, oral non-peptide glucagon-like peptide-1 receptor agonist: A Phase 1a, blinded, placebo-controlled, randomized, single- and multiple-ascending-dose study in healthy participants
Edward Pratt MD, Xiaosu Ma PhD, Rong Liu PhD, Deborah Robins MS, Axel Haupt MD, Tamer Coskun MD, Kyle W. Sloop PhD, Charles Benson MD,Â
doi : 10.1111/dom.15184
Orforglipron (LY3502970), a novel, oral non-peptide glucagon-like peptide-1 receptor agonist: A Phase 1b, multicentre, blinded, placebo-controlled, randomized, multiple-ascending-dose study in people with type 2 diabetes
Edward Pratt MD, Xiaosu Ma PhD, Rong Liu PhD, Deborah Robins MS, Tamer Coskun MD, Kyle W. Sloop PhD, Axel Haupt MD, Charles Benson MD,Â
doi : 10.1111/dom.15150
Crosstalk between genetic variability of adiponectin and leptin, glucose-insulin system and subclinical atherosclerosis in patients with newly diagnosed type 2 diabetes. The Verona Newly Diagnosed Type 2 Diabetes Study 14
Chiara Zusi PhD, Alessandro Csermely MD, Elisabetta Rinaldi PhD, Kezia Bertoldo MD, Sara Bonetti PhD, Maria Linda Boselli MSc, Daniela Travia MD, Enzo Bonora PhD, Riccardo C. Bonadonna MD, Maddalena Trombetta PhD,Â
doi : 10.1111/dom.15152
Liver fibrosis markers and all cause mortality in people with type 2 diabetes: A population based study (The Ayrshire Diabetes Outcomes Cohort (ADOC) Study)
Andrew Collier MD, Christopher Curran MRCP, Lyall Cameron, Sarah H. Wild PhD, Christopher D. Byrne MB BCh,Â
doi : 10.1111/dom.15153
Weight change and risk of obesity-related complications: A retrospective population-based cohort study of a UK primary care database
Kamlesh Khunti F. MedSci, Volker Schnecke PhD, Christiane Lundegaard Haase PhD, Nina M. Harder-Lauridsen PhD, Naveen Rathor MD, Kasper Sommer MSc, Camilla S. Morgen PhD,Â
doi : 10.1111/dom.15154
Trends and disparities in telehealth use among Louisiana Medicaid beneficiaries with type 2 diabetes
Yixue Shao PhD, Lizheng Shi PhD, Elizabeth Nauman PhD, Eboni Price-Haywood MD, Charles Stoecker PhD,Â
doi : 10.1111/dom.15155
Diabetes, fasting blood glucose and the efficacy of remote ischaemic conditioning: A secondary analysis of the RICAMIS trial
Yi-Na Zhang MD, Ying-Jie Dai MD, Yu Cui PhD, Qiong Wu MM, Nan-Nan Zhang MM, Hui-Sheng Chen MD,Â
doi : 10.1111/dom.15156
Serum uric acid lowering and effects of sodium-glucose cotransporter-2 inhibitors on gout: A meta-analysis and meta-regression of randomized controlled trials
Mainak Banerjee DM, Rimesh Pal DM, Indira Maisnam DM, Subhankar Chowdhury DM, Satinath Mukhopadhyay DM,Â
doi : 10.1111/dom.15157
Cost-utility of real-time continuous glucose monitoring versus self-monitoring of blood glucose and intermittently scanned continuous glucose monitoring in people with type 1 diabetes receiving multiple daily insulin injections in Denmark
Hamza Alshannaq MD, Greg Cogswell BSc, Richard F. Pollock MSc, Waqas Ahmed MSc, Greg J. Norman PhD, Peter M. Lynch MPH, Stephane Roze MS,Â
doi : 10.1111/dom.15158
Effects of dietary quality, physical activity and weight loss on glucose homeostasis in persons with and without prediabetes in the PREMIER trial
Vlad Gradinariu MS, Jamy Ard MD, Rob M. van Dam PhD,Â
doi : 10.1111/dom.15160
Safety, tolerability, pharmacokinetics and pharmacodynamics of multiple ascending doses of the novel long-acting glucagon analogue HM15136 in overweight and obese patients with co-morbidities
Wonjung Shin PhD, Marcus Hompesch MD, JinHee Byeon BS, Seohyun Kang MS, Jaehyuk Choi PhD, Seungjae Baek MD,Â
doi : 10.1111/dom.15162
Risk of breakthrough SARS-CoV-2 infection and clinical outcomes among vaccinated patients with type 2 diabetes
Sungho Bea PharmD, Ahhyung Choi PharmD, Jae Hyeon Kim MD, Young Min Cho MD, Won Suk Choi MD, Jaehun Jung MD, Ju-Young Shin PhD,Â
doi : 10.1111/dom.15163
Effects of dapagliflozin compared with glimepiride on body composition in Asian patients with type 2 diabetes inadequately controlled with metformin: The BEYOND study
Hyeong Kyu Park MD, Kyoung-Ah Kim MD, Kyung-Wan Min MD, Tae-Seo Sohn MD, In Kyung Jeong MD, Chul Woo Ahn MD, Nan-Hee Kim MD, Ie Byung Park MD, Ho Chan Cho MD, Choon Hee Chung MD, Sung Hee Choi MD, Kang Seo Park MD, Seoung-Oh Yang MD, Kwan Woo Lee MD,Â
doi : 10.1111/dom.15164
Real-world study of ethnic differences in glycaemic control and clinical characteristics among insulin-naïve people with type 2 diabetes initiating biphasic insulin aspart 30/70: A retrospective, observational cohort study in England
Melanie J. Davies MD, Amra Ciric Alibegovic MD, Anders Boeck Jensen PhD, Renuka Munikrishnappa MD, Rikke Baastrup Nordsborg PhD, Uffe Christian Braae PhD,Â
doi : 10.1111/dom.15165
The association between anthropometric indicators of obesity and cardiac reverse remodelling with empagliflozin in patients with type 2 diabetes and coronary artery disease
Pankaj Puar MSc, Shamon Ahmed MD, Makoto Hibino MD, Aryan Pasricha, Arjun Pandey BHSc, Amaan Bari, Raj Verma, Adrian Quan MPhil, Andrew T. Yan MD, Kim A. Connelly MBBS, Hwee Teoh PhD, C. David Mazer MD, Subodh Verma MD,Â
doi : 10.1111/dom.15119
Efficacy and safety of carbohydrate restriction in patients with type 1 diabetes: A systematic review and meta-analysis
Athina Stamati MSc, Georgia Sotiriou MD, Thomas Karagiannis PhD, Athanasios Christoforidis PhD,Â
doi : 10.1111/dom.15124
Surfing the waves of the COVID-19 pandemic with diabetes mellitus: Analysis of changes in the diabetes therapy, metabolism and physical activity of 92 992 people living with type 1 or type 2 diabetes from the German DPV registry
Bettina Hartmann MD, Sascha René Tittel MSc, Anton Gillesen MD, Barbara Klarl MD, Florian Kopp MD, Svenja Meyhöfer MD, Michael Naudorf MD, Matthias Schilling MD, Frank Jürgen Wosch MD, Reinhard W. Holl MD, for the DPV Initiative ,Â
doi : 10.1111/dom.15149
Comparing the technical reliability and insulin dosing of a “do-it-yourself artificial pancreas� with a commercial hybrid closed-loop system in a “shadow-mode� scenario: An exploratory study
Juri Künzler MD, Thomas Züger MD, Christoph Stettler MD, Markus Wolfgang Laimer MD, Andreas Melmer MD,Â
doi : 10.1111/dom.15161
The novel GIP, GLP-1 and glucagon receptor agonist retatrutide delays gastric emptying
Shweta Urva PhD, Libbey O'Farrell BS, Yu Du PhD, Mei Teng Loh PhD, Andrea Hemmingway PhD, Hongchang Qu PhD, Jorge Alsina-Fernandez PhD, Axel Haupt MD, Zvonko Milicevic MD, Tamer Coskun MD,Â
doi : 10.1111/dom.15167
